Shares in Harvard Bio Tumble 6.10 Percent on Q2 Net Loss | GenomeWeb

NEW YORK, Aug. 9 (GenomeWeb News) - Shares in Harvard Bioscience sank 6.10 percent, or $.20, to 3.08 in mid-afternoon trading after the company reported a 3.3-percent decline in second-quarter revenue atop a net loss.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.